City Therapeutics, Inc.: Jefferies initiates coverage with buy rating; target price $32
CTY•Jefferies initiated coverage of City Therapeutics, Inc. with a buy rating and a $32 target price.
Related News
Wix names president Nir Zohar co-CEO alongside Avishai Abrahami
WIX•
Xencor, Inc.: Piper Sandler raises target price to $49 from $40
XNCR•
Canada's HIVE Digital Q2 revenue falls 2.7% year over year
HIVE•
Cabot Corp: JPMorgan cuts target price to $68 from $78
CBT•
Three worker deaths occurred at effluent treatment plant operated by Ecolab's NALCO Water
ECL•